Generali Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.99M Buy
63,744
+9,473
+17% +$764K 0.09% 197
2026
Q1
$4.7M Buy
54,271
+2,884
+6% +$276K 0.1% 191
2025
Q4
$4.94M Sell
51,387
-18,678
-27% -$1.81M 0.1% 187
2025
Q3
$6.67M Buy
70,065
+29,181
+71% +$2.68M 0.14% 136
2025
Q2
$3.56M Sell
40,884
-34,433
-46% -$2.92M 0.08% 219
2025
Q1
$6.77M Buy
75,317
+36,390
+93% +$3.26M 0.17% 130
2024
Q4
$3.11M Buy
+38,927
New +$3.37M 0.08% 240

Other funds holding MDT

Generali Asset Management's MDT Position: Q2 2026 in Review

Generali Asset Management increased its Medtronic (MDT) stake by 17% in Q2 2026, buying an estimated $764K and bringing the position to 63,744 shares worth $4.99M. The position accounts for 0.09% of the portfolio, ranked #197.

Generali Asset Management first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.77M in Q1 2025. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Generali Asset Management held 63,744 shares of Medtronic worth $4.99M as of Q2 2026.
  • Generali Asset Management bought 9,473 Medtronic shares in Q2 2026, an estimated $764K.
  • Medtronic made up 0.09% of Generali Asset Management's portfolio in Q2 2026, its #197 holding.
  • Generali Asset Management first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's Medtronic position peaked at $6.77M in Q1 2025.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.